A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

“This has killed our entire family. This has brought so much pain and so much hurt for our entire family,” Dzeneta Husic, Sejdinovic’s cousin, said at the lobby of the Regional Justice Center. Family ...

Abdominal pain is considered chronic if it lasts for more than three months. The pain may be constant or it can come and go over the three-month period or longer. There are many health conditions, ...

I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the house listening to audiobooks and doing voice-to-text searches for ...